Vega Iranzo González-Cruz

5PUBLICATIONS
41CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 20, 2026
Axitinib and Long-Acting Octreotide in Advanced Extrapancreatic Neuroendocrine Tumors: A Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trial (AXINET, GETNE 1107).

Rocio Garcia-Carbonero, Marta Benavent, Paula Jimenez-Fonseca

|Apr 28, 2025
Second-Line Endocrine Therapy With or Without Palbociclib Rechallenge in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: PALMIRA Trial.

Antonio Llombart-Cussac, Catherine Harper-Wynne, Antonia Perelló

|Mar 27, 2025
CDK4/6 inhibitors for metastatic breast cancer in routine clinical practice in Spain: survey of patterns of use and oncologists' perceptions.

F Moreno, V Iranzo, I Álvarez

|Aug 26, 2022
Relation of Malnutrition and Nosocomical Infections in Cancer Patients in Hospital: An Observational Study.

Bianca Tabita Muresan, Martín Núñez-Abad, Ana Artero

|Feb 22, 2021
Update on systemic treatment in early triple negative breast cancer.

Martín Núñez Abad, Silvia Calabuig-Fariñas, Miriam Lobo de Mena

Pageof 1